BP LabLine

Call Directions Website Contact the business

BP LabLine A leading U.S. supplier of diagnostic & lab solutions. Advanced tools for clinicians & researchers driving medical progress.

When a measles specimen reaches the lab, one detail can change how the result is interpreted: when it was collected.CDC’...
10/09/2026

When a measles specimen reaches the lab, one detail can change how the result is interpreted: when it was collected.
CDC’s October 2 update reported 3,887 confirmed U.S. measles cases in 2026 as of October 1, with 95% linked to outbreaks.
For laboratory teams, that puts specimen timing, handling, and testing strategy in focus.
Real-time RT-PCR and serum IgM testing provide complementary information. IgM may be negative early after rash onset, while a negative RT-PCR result may not rule out infection when specimen timing or quality is suboptimal.
The questions extend beyond detection. In measles-related research, distinguishing vaccine from wild-type strains—or investigating measles and rubella together—may also be relevant.
BP LabLine carries BioPerfectus real-time PCR assays for both research applications. Details are in the comments.
For Research Use Only. Not for use in diagnostic procedures or patient testing.
For clinical and public health laboratory teams: which step creates the most friction in your workflow—collection, transport, or testing?
Source: CDC | Data as of October 1, 2026; preliminary and subject to change.
MMR vaccination remains the best protection against measles.

New Orleans, we’re looking forward to meeting you! 👋BP LabLine will be at the 2026 APHL Newborn Screening Symposium, Oct...
10/08/2026

New Orleans, we’re looking forward to meeting you! 👋

BP LabLine will be at the 2026 APHL Newborn Screening Symposium, October 11–15.

We’re excited to connect with public health laboratories, newborn screening professionals, and partners to discuss molecular testing workflows—from sample preparation to real-time PCR and the controls that help laboratories assess test validity.
Our team will be highlighting:
🔬 SMN1 and CMV real-time PCR solutions
🧬 Nucleic acid extraction and sample preparation
🤝 Equipment and workflow support for your laboratory
Visit us in the exhibit hall October 12–14. Bring your questions, share your workflow challenges, and get to know our team.

Attending? Leave a comment or message us to arrange a conversation!

Your PCR result is negative. But was the sample ever there? A negative PCR result can mean the target was not detected. ...
10/07/2026

Your PCR result is negative. But was the sample ever there?
A negative PCR result can mean the target was not detected.
But what if the sample was insufficient? What if extraction failed? Or what if something in the reaction inhibited amplification?
These are very different situations — even if the final result looks the same.
That’s why an internal control matters.
It helps laboratories distinguish a valid negative result from a test in which the process may not have worked as expected.
Because in molecular testing, “not detected” and “not successfully tested” are not the same thing.

AI is moving quickly into life science.But for many laboratories, the biggest opportunity isn’t an AI model. It’s elimin...
09/23/2026

AI is moving quickly into life science.

But for many laboratories, the biggest opportunity isn’t an AI model. It’s eliminating the manual step everyone has learned to work around.

That step might be:
• Re-entering sample information across systems
• Moving samples between tubes, racks, and plates
• Waiting for one experienced operator to complete a process
• Repeating a run because of preventable handling variation
A useful way to think about laboratory automation is as a progression:
1. Manual — most steps depend on individual operators
2. Assisted — tools reduce repetitive physical work
3. Connected — instruments, sample tracking, and data move together
4. Intelligent — systems help identify exceptions, anticipate capacity, and support decisions

Not every workflow needs to reach level four.
Sometimes the most valuable improvement is simply moving one high-volume process from manual to assisted—or connecting two steps that currently rely on transcription.

Before asking, “How can we use AI in the lab?” it may be more useful to ask:
Where does our workflow still depend on repetition, memory, or manual handoffs?
Where would you place your laboratory today—and what would help it reach the next level?

September 30 marks the end of the U.S. federal fiscal year. But does that mean every NIH-funded laboratory must spend it...
09/22/2026

September 30 marks the end of the U.S. federal fiscal year. But does that mean every NIH-funded laboratory must spend its remaining budget by then?
Not necessarily.
A grant’s budget period may end at a different point in the year, and the treatment of an unobligated balance depends on the award terms and institutional policies. For laboratory teams, the more useful question is not simply, “What can we spend before September 30?” It is, “What does our specific funding and procurement timeline require?”
A practical end-of-September review might include:
1. Confirm the actual budget period
Check the dates and terms attached to the award rather than assuming they align with the federal fiscal year.
2. Review institutional purchasing requirements
Internal approvals, competitive bidding thresholds, and cooperative purchasing options can affect how quickly a request moves forward.
3. Verify availability and lead times
A quote does not guarantee that an instrument can arrive within the required period. Confirm inventory, shipping estimates, installation needs, and any site preparation before committing funds.
4. Look beyond major instruments
Blades, tips, tubes, adaptors, replacement parts, and other routine consumables are easy to overlook—but often become the items that interrupt an experiment later.
5. Plan for upcoming policy changes
NIH is currently accepting public comments on its Draft Biosafety Policy for Research Involving Biohazards through October 19, 2026. Once finalized, the policy will replace the current NIH Guidelines for research involving recombinant or synthetic nucleic acid molecules.
Year-end planning is most useful when it supports the next stage of the research—not when it creates unnecessary urgency.
What is your laboratory reviewing this month: budget timelines, procurement requirements, equipment lead times, or essential consumables?
Relevant NIH and procurement resources are included in the comments.

BP LabLine is heading to MHEC Expo 2026.As an awarded MHEC contract supplier, we’re proud to support colleges, universit...
09/21/2026

BP LabLine is heading to MHEC Expo 2026.
As an awarded MHEC contract supplier, we’re proud to support colleges, universities, and research institutions with access to laboratory equipment and supplies from multiple technology partners.
Our team member Xueyi will be onsite to learn about your laboratory’s current needs, upcoming projects, and procurement priorities—and help identify solutions that fit your workflow and budget.
📅 September 24, 2026
📍 DCU Center | Worcester, Massachusetts
Attending the expo? We look forward to connecting with you.

Pathology is becoming more connected—but connectivity cannot begin only after the report is finalized.The CDC recently r...
09/17/2026

Pathology is becoming more connected—but connectivity cannot begin only after the report is finalized.
The CDC recently reported that its electronic pathology initiative now receives daily cancer pathology reports from 78 laboratories, representing more than 500 CLIA-certified facilities. The broader direction is clear: pathology data is moving toward faster, more structured, and more interoperable exchange.
But every digital record still begins with a physical specimen.
Before information can move between laboratories, registries, and health systems, specimen identity must remain consistent as tissue moves from cassette to block to slide.
For laboratories, connected pathology therefore involves both sides of the workflow:
• Structured digital data exchange
• Reliable physical sample identification
• Fewer disconnected manual-entry steps
• Systems that work with existing laboratory infrastructure
The future of pathology is not only digital. It is connected from the specimen forward.
Learn more about BP LabLine’s Histology Sectioning & Connected Identification Solutions. Links in the comments.

This Labor Day, BP LabLine celebrates the people whose dedication keeps science moving forward—from the laboratory profe...
09/07/2026

This Labor Day, BP LabLine celebrates the people whose dedication keeps science moving forward—from the laboratory professionals behind every experiment to the teams supporting every step of the workflow.
Thank you for the skill, care, and persistence you bring to every discovery.
Wishing our customers, partners, and colleagues a safe and restful Labor Day.

08/24/2026

96 wells. 12 columns. One missed step can mean starting over.
Multi-channel pipetting makes plate-based workflows faster—but when the protocol involves repeated dispensing across an entire 96-well plate, it’s surprisingly easy to lose track:
Which column did I just finish?
Where should I pipette next?
Did I accidentally skip—or repeat—a row?
With plate navigation built into the intelligent pipetting workflow, each dispensing step follows a predefined protocol, guiding users through the plate in sequence.
For repetitive plate-based workflows such as qPCR setup, ELISA, cell-based assays, and reagent distribution, this means:
✓ Less mental tracking during repetitive pipetting
✓ Lower risk of skipped or duplicated wells
✓ More consistent ex*****on across the plate
✓ A smoother workflow from the first well to the last
The pipette handles the volume.
The workflow keeps you on track.
See multi-channel plate navigation in action. 👇

08/21/2026

When qPCR setup involves different volumes, the real challenge is not only pipetting — it is keeping the plate plan under control.
Before qPCR, many researchers need to normalize samples to the same input amount.
But in real workflows, every sample may require a different volume.
That means:
checking the concentration table,
adjusting the pipette volume again and again,
matching each sample to the correct well,
and trying not to lose track of the plate layout.
The more samples you have, the easier it is for small mistakes to happen.
This is where a smart single-channel pipette can make the workflow more manageable.
With a pre-set pipetting protocol and plate navigation, researchers can follow the planned steps directly:
which well to go to,
what volume to aspirate or dispense,
and what step comes next.
No repeated manual volume adjustment.
No constant checking back and forth.
Less pressure during complex plate setup.
For qPCR normalization, serial dilution, or irregular plate layouts, the value is not just automation.
It is helping researchers handle different volumes and different wells with more confidence.

Address

12 Michigan Drive
Natick, MA
01760

Alerts

Be the first to know and let us send you an email when BP LabLine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to BP LabLine:

Shortcuts

Share